Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Slides:

Advertisements

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results M. Ferreira, L. Lanziotti, M. Monteiro, G.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease Gilbert R. Upchurch,

Mid-term outcomes of endovascular popliteal artery aneurysm repair

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery Donald T. Baril, MD, Robert Y.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Karan Garg, MD, Caron B. Rockman, MD, Billy J. Kim, MD, Glenn R

Stenting of femoropopliteal lesions using interwoven nitinol stents

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease Hasan H. Dosluoglu, MD, Purandath Lall,

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions Takao Ohki, MD, PhD, Kimihiko.

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Duplex ultrasound criteria for femorofemoral bypass revision

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Regulatory TEVAR clinical trials

Miguel Montero-Baker, MD, Gregory J

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Open versus endovascular treatment of subclavian artery atherosclerotic disease George C. Galyfos, MD, PhD, Ioannis Kakisis, MD, PhD, Chrisostomos Maltezos,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Christopher J. Smolock, MD, Javier E

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,

Abd Moain Abu Dabrh, MBBCh, MS, Mark W

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Patrick A. Stone, MD, John E. Campbell, MD, Karinna H

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease Brant W. Ullery,

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Primary stenting of the superficial femoral and popliteal artery

Reply Journal of Vascular Surgery

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

IP095. Severe Tandem Carotid Lesions in an Irradiated Field with Tracheostomy and Contralateral Carotid Occlusion and Contraindication to Carotid Artery.

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Duplex-guided balloon angioplasty and stenting for femoropopliteal arterial occlusive disease: An alternative in patients with renal insufficiency Enrico.

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Santiago Chahwan, MD, M. Todd Miller, MD, John P. Pigott, MD, Ralph C

Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K

Endoscopic vein harvest for infrainguinal arterial bypass

Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts. A EUROSTAR report Roel Hobo, MSc, Jacob Buth,

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions

Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery Luis R. León, MD, RVT, Robert.

Early results of stent-grafting to treat diffuse aortoiliac occlusive disease Eva M Rzucidlo, MD, Richard J Powell, MD, Robert M Zwolak, MD, PhD, Mark.

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England Ryan M. Svoboda, Karina A.

Progression of internal carotid artery stenosis in patients with peripheral arterial occlusive disease Afshin S. Jahromi, MD, MSc (HRM), Catherine M.

Femorofemoral bypass with femoral popliteal vein

Midterm outcomes of the Zenith Renu AAA Ancillary Graft

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Determinants of successful peroneal artery bypass

Endovascular interventions for TASC II D femoropopliteal lesions

Ultrasound velocity criteria for renal in-stent restenosis

Thigh claudication due to profunda femoris artery occlusion

Presentation transcript:

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease Patrick J. Geraghty, MD, Mark W. Mewissen, MD, Michael R. Jaff, DO, Gary M. Ansel, MD Journal of Vascular Surgery Volume 58, Issue 2, Pages 386-395.e4 (August 2013) DOI: 10.1016/j.jvs.2013.01.050 Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 1 Primary patency (peak systolic velocity ratio [PSVR] ≤ 2.0). Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 2 Primary-assisted patency. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 3 Secondary patency. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 6 Freedom from first reintervention. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 4 (online only) Primary patency using alternate criterion of peak systolic velocity ratio (PSVR) ≤ 2.5. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Fig 5 (online only) Primary patency using alternate criterion of peak systolic velocity ratio (PSVR) ≤ 3.0. Journal of Vascular Surgery 2013 58, 386-395.e4DOI: (10.1016/j.jvs.2013.01.050) Copyright © 2013 Society for Vascular Surgery Terms and Conditions